Hexagon Bio
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Their proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
[overview]
stage
founded
region
fund
[details]